跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
黃 奕文
副教授
,
消化內科
https://orcid.org/0000-0002-5196-7030
電子郵件
yiwenhuang
tmu.edu
tw
h-index
1560
引文
20
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2004
2026
每年研究成果
概覽
指紋
網路
專案
(2)
研究成果
(65)
類似的個人檔案
(6)
指紋
查看啟用 Yi-Wen Huang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Hepatitis B
83%
Ropeginterferon Alpha2b
77%
Chronic Hepatitis C
41%
Pharmacokinetics
39%
Hepatitis B Virus
37%
Cohort Study
31%
Liver Cell Carcinoma
29%
Peginterferon
28%
Liver Cirrhosis
28%
Interferon
26%
Clinical Trial
18%
Fatty Liver
18%
Entecavir
18%
Pharmacodynamics
17%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
17%
Adverse Event
13%
Hepatitis B Antigen
13%
Hepatitis B
11%
Virus Hepatitis
10%
Hepatitis B(e) Antigen
10%
Prospective Study
10%
Lamivudine
9%
Rifampicin
8%
Drug Resistant Tuberculosis
8%
Leukocyte Antigen
8%
Cancer Chemotherapy
8%
Off-Label Use
8%
Hepatitis C
8%
Cardiovascular Disease
8%
Biochemical Recurrence
8%
Tuberculosis
8%
Tenofovir
8%
2,5-Dimethoxy-4-iodoamphetamine
8%
Alcohol Liver Disease
8%
Drug Safety
8%
Hepatitis
8%
Esophagus Varices
8%
Hepatitis C Virus
6%
Virus Carrier
6%
Steatosis
6%
Peginterferon Alpha2a
5%
Macrogol
5%
Polycythemia vera
5%
Ribavirin
5%
Infection
5%
Diseases
5%
Medicine and Dentistry
Chronic Hepatitis B
52%
Hepatocellular Carcinoma
36%
Cohort Analysis
28%
Diabetes
28%
Liver Cirrhosis
26%
Hepatitis B
20%
Hepatitis B Virus
19%
Chronic Hepatitis C
17%
Alcohol Liver Disease
17%
Esophageal Varices
17%
Lamivudine
17%
Rifampicin
17%
Drug Resistant Tuberculosis
17%
Platelet
16%
Tuberculosis
15%
Fatty Liver
11%
Alcohol Liver Cirrhosis
10%
Quinolone Derivative
10%
Prospective Study
10%
Clofazimine
10%
Hepatitis B Antigen
9%
Entecavir
9%
Peginterferon
8%
Nonalcoholic Fatty Liver
8%
Small Cell Lung Cancer
8%
Adrenal Insufficiency
8%
Acquired Immune Deficiency Syndrome
8%
Narrow Band Imaging
8%
Hepatitis Virus
8%
Budd-Chiari Syndrome
8%
Kidney Transplantation
8%
Heart Transplantation
8%
Acute Pancreatitis
8%
Gut Microbiota
8%
Solid Organ Transplantation
8%
Interferon
8%
Extensively Drug Resistant Tuberculosis
8%
QT Prolongation
8%
Pathogenesis
8%
Adverse Event
8%
High Fat Food
8%
Hepatitis
8%
Diagnostic Test
8%
Long QT Syndrome
8%
Metabolite
8%
Drug Safety
8%
Multidrug Resistant Tuberculosis
8%
Lung Tuberculosis
8%
Cardiovascular Disease
8%
Hazard Ratio
8%
Immunology and Microbiology
Hepatitis B
100%
HBsAg
36%
Hepatitis B Antigen
36%
Hepatitis B Virus
35%
Interferon Type I
19%
Gnotobiotics
17%
Infectious Disease
15%
Infection
15%
HBV DNA
15%
Pegylated Interferon
14%
Alanine
13%
Viral Load
13%
Ribonucleic Acid
12%
Hepatitis B(e) Antigen
11%
Intestine Flora
11%
Lipid Storage
10%
Viral Replication
8%
TLR9
8%
Immunoglobulin M Antibody
8%
Solid Organ Transplantation
8%
Monocyte
8%
Hepatitis C Virus
8%
HBcAg
8%
TLR3
8%
Steatohepatitis
8%
Metabolite
8%
Life Expectancy
8%
Immunosuppressant
8%
Bacterium
8%
Peroxisome
6%
Hepatitis B Core Antibody
5%
Inflammation
5%
Seroconversion
5%
Cirrhosis
5%
Normal Human
5%
Fatty Acid
5%
